{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:23:55Z","timestamp":1790274235848,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Wayne State University start-up funding to AKI"},{"name":"Department of Veterans Affairs Merit Review to AKR"},{"name":"College of Pharmacy at Taif University and Saudi Arabian Cultural Mission"},{"DOI":"10.13039\/501100008982","name":"NSF","doi-asserted-by":"publisher","award":["#0216084"],"award-info":[{"award-number":["#0216084"]}],"id":[{"id":"10.13039\/501100008982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 CA022453"],"award-info":[{"award-number":["P30 CA022453"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biomaterials.2018.08.053","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T05:33:30Z","timestamp":1535607210000},"page":"280-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages"],"prefix":"10.1016","volume":"183","author":[{"given":"Hashem O.","family":"Alsaab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaresh","family":"Sau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami M.","family":"Alzhrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vino T.","family":"Cheriyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Polin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulka","family":"Vaishampayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Rishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2018.08.053_bib1","first-page":"1","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/CBM-2011-0176","article-title":"Renal cell carcinoma","volume":"9","author":"Cairns","year":"2011","journal-title":"Canc. Biomarkers"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Creighton","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jgg.2015.03.003","article-title":"The PI3K\/AKT pathway and renal cell carcinoma","volume":"42","author":"Guo","year":"2015","journal-title":"J. Genet. Genom."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2407-13-331","article-title":"Effects of hypoxia on human cancer cell line chemosensitivity","volume":"13","author":"Strese","year":"2013","journal-title":"BMC Canc."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.urolonc.2007.12.001","article-title":"Clinical implications of hypoxia inducible factor in renal cell carcinoma","volume":"27","author":"Smaldone","year":"2009","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.hoc.2011.04.008","article-title":"MTOR inhibitors in advanced renal cell carcinoma","volume":"25","author":"Voss","year":"2011","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13045-016-0374-y","article-title":"New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy","volume":"10","author":"Zarrabi","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1470-2045(09)70240-2","article-title":"Resistance to targeted therapy in renal-cell carcinoma","volume":"10","author":"Rini","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 Checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib11","first-page":"85208","volume":"vol. 7","author":"Juengel","year":"2016"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ctrv.2016.09.002","article-title":"Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy","volume":"50","author":"Calvo","year":"2016","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib13","series-title":"The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity in vitro","author":"Krusch","year":"2017"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib14","first-page":"262","article-title":"Sequential targeted therapy after Pazopanib therapy in patients with metastatic renal cell Cancer\u202f: Ef fi cacy and toxicity","volume":"12","author":"Bellmunt","year":"2014","journal-title":"Clin. Genitourin. Canc."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10555-007-9094-7","article-title":"Tumour vascularization: sprouting angiogenesis and beyond","volume":"26","author":"Hillen","year":"2007","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib16","series-title":"A CARP-1 Functional Mimetic Loaded Vitamin E-TPGS Micellar Nano-formulation for Inhibition of Renal Cell Carcinoma","author":"Cheriyan","year":"2017"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib17","series-title":"Carbonic Anhydrase IX ( CAIX ) as a Mediator of Hypoxia-induced Stress Response in Cancer Cells","first-page":"255","author":"Mcdonald","year":"2014"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib18","first-page":"412","article-title":"Value of MN\/CAIX in the diagnosis of renal cell carcinoma, Nan Fang Yi Ke da Xue Xue Bao","volume":"32","author":"Jiang","year":"2012","journal-title":"J. South. Med. Univ."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib19","first-page":"262","article-title":"Prognostic factors in patients with advanced renal cell carcinoma","volume":"10","author":"L\u00f3pez","year":"2012","journal-title":"Clin. Genitourin. Canc."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib20","first-page":"2827","article-title":"Identification of the MN\/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney","volume":"57","author":"Liao","year":"1997","journal-title":"Canc. Res."},{"issue":"19","key":"10.1016\/j.biomaterials.2018.08.053_bib21","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1158\/1078-0432.CCR-09-3343","article-title":"Biomarkers predicting outcome in patients with advanced renal cell carcinoma: results from sorafenib phase III TARGET","volume":"16","author":"Pe\u00f1a","year":"2010","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib22","first-page":"1788","article-title":"Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET)","author":"Choueiri","year":"2013","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1464-410X.2010.09218.x","article-title":"Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy","volume":"106","author":"Choueiri","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib24","series-title":"Carbonic Anhydrase Inhibitor Suppresses Invasion of Renal Cancer Cells in vitro","author":"Waheed","year":"2000"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1464-410X.2010.09314.x","article-title":"Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250","volume":"107","author":"Oosterwijk-Wakka","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrclinonc.2012.59","article-title":"Treatment selection in metastatic renal cell carcinoma: expert consensus","volume":"9","author":"Escudier","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib27","volume":"vol. 7","author":"Minn","year":"2016"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib28","doi-asserted-by":"crossref","unstructured":"C.H.J. Muselaers, A.B. Stillebroer, M. Rijpkema, G.M. Franssen, E. Oosterwijk, P.F.A. Mulders, W.J.G. Oyen, O.C. Boerman, Anhydrase IX Monoclonal Antibody Girentuximab, (n.d.) 1035\u20131041. doi:10.2967\/jnumed.114.137356.","DOI":"10.2967\/jnumed.114.137356"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib30","doi-asserted-by":"crossref","unstructured":"N. Krall, F. Pretto, M. Mattarella, D. Neri, Tc-labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma in Vivo, (n.d.) 943\u2013950. doi:10.2967\/jnumed.115.170514.","DOI":"10.2967\/jnumed.115.170514"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib31","series-title":"A. Manuscript, NIH Public Access","year":"2015"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib32","first-page":"3808","volume":"vol. 26","author":"Brouwers","year":"2017"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.4155\/tde-2017-0062","article-title":"Nanomedicine for cancer diagnosis and therapy: advancement, success and structure\u2013activity relationship","volume":"8","author":"Bhise","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.drudis.2016.12.009","article-title":"Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy","volume":"22","author":"Wickens","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.colsurfb.2017.06.025","article-title":"Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers","volume":"157","author":"Luong","year":"2017","journal-title":"Coll. Surf. B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib36","article-title":"Advances in antibody-drug conjugates: a new era of targeted cancer therapy","volume":"00","author":"Sau","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/pharmaceutics9020015","article-title":"Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma","volume":"9","author":"Alsaab","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib39","article-title":"Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib40","doi-asserted-by":"crossref","first-page":"73370","DOI":"10.18632\/oncotarget.12333","article-title":"CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers","volume":"2","author":"Cheriyan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib41","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.juro.2010.02.423","article-title":"356 secreted frizzled-related PROTEIN-5 (SFRP-5) is epigenetically downregulated and functions as a tumor suppressor in renal cell cancer","volume":"183","author":"Kawakami","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib42","article-title":"Metabolic reprogramming for producing Energy and reducing power in fumarate hydratase null cells from hereditary Leiomyomatosis renal cell carcinoma","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ejmech.2017.07.027","article-title":"Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues","volume":"138","author":"Almansour","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib44","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1016\/j.tetlet.2013.10.103","article-title":"Heteropoly acid catalyzed synthesis of 8-methyl-2-aryl\/alkyl-3- oxabicyclo[3.3.1]non-7-ene derivatives through (3,5)-oxonium-ene reaction","volume":"54","author":"Anjibabu","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib45","first-page":"40","article-title":"Cobalt chloride-induced hypoxia induces Epithelial-mesenchymal transition in renal carcinoma cell lines","volume":"47","author":"Zhang","year":"2017","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib46","doi-asserted-by":"crossref","first-page":"15874","DOI":"10.1038\/ncomms15874","article-title":"Long noncoding RNA LncHIFCAR\/MIR31HG is a HIF-1$\u03b1$ co-activator driving oral cancer progression","volume":"8","author":"Shih","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib47","article-title":"CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer","author":"Wang","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib48","first-page":"1","article-title":"Pulmonary delivery of triptolide- loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy","author":"Lin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib49","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcis.2017.01.092","article-title":"Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue","volume":"496","author":"Gawde","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib50","first-page":"1","article-title":"Combination of cationic dexamethasone derivative and STAT3 inhibitor (WP1066) for aggressive melanoma: a strategy for repurposing a phase I clinical trial drug","author":"Sau","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib51","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2017.03.023","article-title":"Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: in vitro and ex vivo studies","volume":"253","author":"Sahu","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jconrel.2016.11.023","article-title":"Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma","volume":"246","author":"Dal Corso","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib53","series-title":"Transthiocarbamoylation of Proteins by Thiolated","author":"Shibata","year":"2011"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib54","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1021\/acs.molpharmaceut.6b00065","article-title":"Evaluation of a carbonic anhydrase IX-targeted near-infrared dye for fluorescence-guided surgery of hypoxic tumors","volume":"13","author":"Lv","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib55","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1158\/1078-0432.CCR-15-2640","article-title":"A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer, Clin","volume":"22","author":"Hoogstins","year":"2016","journal-title":"Canc. Res."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib56","article-title":"Ich harmonised tripartite guideline validation of analytical Procedures","author":"I.C. on Harmonisation","year":"2005","journal-title":"ICH Harmon. Tripart. Guidel. Valid. Anal. Proced. TEXT Methodol."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib57","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/j.biomaterials.2012.03.046","article-title":"Vitamin E TPGS as a molecular biomaterial for drug delivery","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib58","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1002\/adma.201301232","article-title":"Hydrophobic anticancer drug delivery by a 980 nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo","volume":"25","author":"Dong","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib59","article-title":"Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma","author":"Pastorekova","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050860","article-title":"Vivo imaging and Quantification of carbonic anhydrase IX expression as an Endogenous biomarker of tumor hypoxia","volume":"7","author":"Bao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000082713","article-title":"CA9 expression as a prognostic factor in renal clear cell carcinoma","volume":"74","author":"Soyupak","year":"2005","journal-title":"Urol. Int."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib62","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1158\/1078-0432.CCR-05-2253","article-title":"A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma, Clin","volume":"12","author":"Uemura","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib63","doi-asserted-by":"crossref","first-page":"12042","DOI":"10.1039\/C4NR03819C","article-title":"Ultrasmall biomolecule-anchored hybrid GdVO 4 nanophosphors as a metabolizable multimodal bioimaging contrast agent","volume":"6","author":"Dong","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib64","doi-asserted-by":"crossref","first-page":"38000","DOI":"10.1074\/jbc.M111.222398","article-title":"Antagonists of Anaphase-promoting Complex (APC)-2-Cell Cycle and Apoptosis Regulatory Protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis","volume":"286","author":"Puliyappadamba","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib65","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.18632\/oncotarget.3376","article-title":"CARP-1\/CCAR1: a biphasic regulator of cancer cell growth and apoptosis","volume":"6","author":"Muthu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib66","series-title":"Semin. Cell Dev. Biol","first-page":"98","article-title":"Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: a braided cancer river model of kidney cancer","author":"Hsieh","year":"2017"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib67","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/cncr.26429","article-title":"Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma","volume":"118","author":"Molina","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40169-016-0123-4","article-title":"A braided cancer river connects tumor heterogeneity and precision medicine","volume":"5","author":"Hsieh","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib69","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/blood-2013-05-501494","article-title":"Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9","volume":"122","author":"Zajac","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2018.01.028","article-title":"Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment","volume":"274","author":"Sau","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2018.08.053_bib71","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.4049\/jimmunol.1402550","article-title":"NF-\u03baB regulates PD-1 expression in macrophages","volume":"194","author":"Bally","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrclinonc.2016.212","article-title":"Beyond the margins: real-time detection of cancer using targeted fluorophores","volume":"14","author":"Zhang","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2018.08.053_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218306136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218306136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:39:07Z","timestamp":1758904747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961218306136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":73,"alternative-id":["S0142961218306136"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.08.053","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.08.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}